Aggiornato alle 07:26 16°
Qui la tua pubblicità 970×90320×100 · Contattaci »
Italia

Gene2Cure Foundation and Viralgen collaborate to advance a portfolio of gene therapy programs for rare and ultra-rare genetic conditions

Fonte: Adnkronos Adnkronos · aggiornato

(Adnkronos) - Collaboration brings together Gene2Cure's portfolio development capabilities and Viralgen's proprietary Aava™ platform to support the efficient progression of programs for rare and ultra-rare genetic conditions toward the clinic…

Continua a leggere su Adnkronos
Qui la tua pubblicità 728×90300×250 · Contattaci »

Come ne parlano i media 1

Adnkronos
Gene2Cure Foundation and Viralgen collaborate to advance a portfolio of gene therapy programs for rare and ultra-rare genetic conditions

(Adnkronos) - Collaboration brings together Gene2Cure's portfolio development capabilities and Viralgen's proprietary Aava™ platform to support the efficient progression of programs for rare and ultra-rare genetic conditions toward the clinic.

Leggi →

Temi

↑